dr. robinson. dr.borio, for five minutes. >> thank you, chairman murphy. >> pull the microphone as close as possible. >> thank you, chairman murphy, ranking memet ismiyati per degette and subcommittee. we want to respond to the ebola epidemic a tragic global event. my colleagues and i at fda are determined to do all we can to end it as quickly as possible. the desire and need fo andfe effective vaccines and treatments is overwhelming. fda's taken extraordinary steps to be proactive and flexible. we're levera authorities and working diligently to expedite the development, manufacturing availability of safe and effective medical products for ebola. we're providing the fda with a unique, scientific regulatory advice to companies to guide their submissions. we're reviewing data as it is received. these action advance the development of and investigation of products as quickly as possible and for example, in case of two vaccines that dr. fauci mentioned, fda took only a few days to review the applications a

dr. robinson. a former vaccine developer in the industry. for the last ten years, a public working on pandemic preparedness and many other biothreats. it was created, the government agency responsible for supporting advance developments of medicalent countermeasures such as vaccines, therapeutic drugs, the entire nation. it exists to address the medical consequences of biothreats and emerging infectious diseases. we responded to emergency h1n1, pandemic in 2009, and avian influenza in year.last today we are immersed in responding to ebola, which is withtaneously a biothreat a material threat determination. infectiousging disease. as you have said, when it comes andbola as a biothreat emerging infectious disease, the best way to protect our country the currents epidemic in africa. we work with our federal to transition the federal countermeasures from early development and to advance towards ultimate fda approval. since 2006, we have built an advance development pipeline of more than 150 countermeasures threats and pandemic influenza. seven o

dr. robinson. a former vaccine developer in the industry. a publicast ten years, servant working on pandemic preparedness and many other biothreats. the government agency responsible for supporting advanced development and of innovative medical countermeasures, such as vaccines, and medical devices for the entire nation. thea exists to address medical consequences of biothreats. supported medical developments on a routine basis and responded to emerging threats like h1n1, pandemic in avian influenza. today we are immersed in isponding to ebola, which simultaneously a biothreat with a material threat determination. and an emerging infectious disease. as you have said, and my colleagues have said, when it comes to ebola as a biothreat, the best way to protect our is to address the current epidemic in africa, the worst on record. with its federal partners to transition the medical countermeasures from to advanceopment and development towards ultimate fda approval. have built an advanced development pipeline of more than 150 medical countermeasu

dr. robinson for five minutes. we'll hear your statement. >> good afternoon, chairman murphy, chairman upton, ranking members. and other distinguished members of the subcommittee. thank you for the opportunity to speak with you today about our efforts by the government on ebola. i am dr. robin robinson a former vaccine developer in the industry and for last 10 years a public servant working on pandemic preparedness and many other bio threats. barta was prepared in 2006 as the government agency responsible for supporting advanced developments and brodeur. of novel and innovate he measures such as vaccines, therapeutic drugs, diagnostics and medical devices for the entire nation. barda exists to address the medical consequences of bio threats and emerging infectious diseases. it has supported man-made threats on a routine basis under project bio and responded to emerging threats. pan dekanich thousand nine and the influenza in china last year. today we are emersed in respond to go ebola which is a bio threat with a m

dr. robin robinson the director of biomedical advanced research and development authority within the ofrts of the assistant secretary for preparedness and response at the united states department of health and human services. dr. boreo is assistant commissioner at the u.s. food and drug administration. mr. john p. wagner the acting assistant commissioner of the office of field operations within u.s. customs and border protection at the homeland security and joining us today on video conference from texas dr. daniel varga chief clinical officer and senior vice president of the texas health resources. joining us in a moment. i will swear in the witnesses. you are all aware that the committee is holding an investigative hearing and when doing so, has had the practice of taking it testimony under oath. do any of you have any obje objections taking testimony under oath? >> witnesses say no. dr. varga? >> no. >> thank you. the chair then advises you that under the rules of the house and the rules of the committee you are entitled to be advised by own sell. do any of you? >> no. >> everyone answe

dr. robinson? >> good afternoon, chairman durfee, chairman upton, and others of the subcommittee. thank you for the opportunity to speak today by the efforts on the ebola. i am dr. robertson, a former vaccine developer, and i have been working on pandemic and bio threats. is the government agency responsible for supporting advanced development and procurement of novel countermeasures such as vaccines, drugs, diagnostics, and medical devices for the entire nation. barda exists to address consequences of violence rates best of bio threats. it supports development for man-made threats on a routine basis to respond to emerging like h1n1. today we are responding to ebola . said, when it comes to ebola, the best way to protect our country is to address the current epidemic in africa. barda works with partners to transition the countermeasures from early development into advanced the moment towards ultimate fda approval. since 2006 we have built an advanced pipeline of more than 150 countermeasures for threats. have of these products been fda approved in the last two years, and today we a

dr. robinson? >> good afternoon, chairman durfee, chairman upton, and others of the subcommittee. thank you for the opportunity to speak today by the efforts on the ebola. i am dr. robertson, a former vaccine developer, and i have been working on pandemic and bio threats. is the government agency responsible for supporting advanced development and procurement of novel countermeasures such as vaccines, drugs, diagnostics, and medical devices for the entire nation. barda exists to address consequences of violence rates best of bio threats. it supports development for man-made threats on a routine basis to respond to emerging like h1n1. today we are responding to ebola . said, when it comes to ebola, the best way to protect our country is to address the current epidemic in africa. barda works with partners to transition the countermeasures from early development into advanced the moment towards ultimate fda approval. since 2006 we have built an advanced pipeline of more than 150 countermeasures for threats. have of these products been fda approved in the last two years, and today we a

dr. robinson, can you tell us what hhs is doing to make sure that those contracts are moving forward as quickly as possible? >> thank you, sir. we have reviewed their proposal. it looks very favorable. and we will be over the next several weeks finalizing the negotiations with them. prior to that we have been helping them with their submissions to the fda in providing assistance on-site and also at the manufacturing science in working to expand their production with other companies including a large kp here in the united states. >> and also, mr. braley. >> yes. >> the hhs is also involved in the other end of it because the trials that were started, were not only in collaboration with the department of defense, but we admitted our first dsv patient at our clinical center in bests they a da for a phase one trial. not only in the testing but in the ultimate production. >> it's my understanding, dr. fauci and robinson, that the ultimate goal is to also expand this clinical testing into some of the affected regions in africa as well once we have an understanding of some of the concerns that were ide

dr. robinson, ultimate goal is to land his clinical testing into the affected regions in africa as well once we have an understanding of some of the concerns that ride in a fight earlier in your testimony's death that were identified earlier in your testimony 00 --that were identified earlier in your testimonies. >> if they are safe and reduce the response we feel is appropriate, we will expand both of them into larger trials in west africa. bama mr. wagner, we have heard a lot about the issue of travel restrictions. can you walk us through the strengths and weaknesses of that approach from your standpoint in border security? >> time is expired so if you could give a quick answer -- >> we have the ability to use the data the airlines give us to see where travelers originating from. there are instances where travelers may go to different locations and we might not see that, but through our questioning and view, we can identify safe and duties affected regions or if they come through one of the borders, if they fled to canada or mexico. it is more difficult for us to do it but the possibility

dr. robinson trains nurses on how to wear the protect ufsh gear. >> we need better guidelines. the only way the in urs can be properly educated and trained is if the administrators and the trainers do have the proper guidelines of what to say, what to do. >> both nurses are now being treated at medical centers outside of dallas. the cdc is expected to issue new guidelines to protect health care workers nationwide. >>> yesterday in north carolina, friends and family of thomas eric duncan remembered him at a memorial service. the cdc and health officials are looking into mistakes that may have led to his initial misdiagnosis of duncan. and again, the two nurses who were infected. >>> here at home, members of philadelphia's liberian community are raising awareness about ebola through their musical heritage. liberian women's chorus for change performed at a public forum in southwest philadelphia last night. the four women are among the 10,000 liberian refugees who settled here after years of civil war. now their country is fighting ebola. the group told us that they are ready for t

dr. frieden stressed quick detection can make all the difference. joining me now, todd robinson. todd, nice to have you on. >> thanks for having me. >> so just reading your piece in the paper, the headline said it to me. "thomas duncan did not have to die." you argue a few more questions and better communication could have saved this man's life. the fact that he was highly contagious when he first went to that hospital and then was sent home, how did that happen? >> it was the lack of verbal communication between nurses and doctors. the people who were on the front lines dealing with him. they were too busy putting information into their computers or writing it down on their clipboards and they didn't bother to relay crucial information by voice that would have warned them this was a special case. this was someone who had just come from liberia. >> we are asking the same questions that you and other reporters are. one reporter earlier in the week asked a question of the texas department of health saying there was a flaw in the electronic system and backed off saying it's being lo

dr. tom frieden is the director the centers for disease control and prevention. is with the national institutes of health. of robinsonis the director biomedical advance research within the office of the assistant secretary for preparedness and response at the united states department of health. dr. boreo is the assistant commissioner for counterterrorism policy. mr. john wagner is the acting assistant commissioner of the office of field operations the u.s. customs and border protection. us today from video conference will be dr. daniel the chief clinical officer at the texas health resources. he'll be joining us in a moment. witnesses.ear in the you are all aware that the committee is holding an investigative hearing and when doing so has had the practice of taking testimony under oath. have any you objections taking testimony under oath? say no.esses and dr. varga? >> no. >> thank you. you that then advises under the rules of the house, and the rules of the committee, you are entitled to be advised counsel. do any of you desire to be advised by counsel during your testimony today? dr. varga? >> no. >> everyone answe

robinson bat. i still remember. it had a thick handle. everybody who came through, everybody from stokely carmichael to dr. king and it was an experience. it was fascinating. there were several stories about the movement in the book. -- at old miss now, and among the things i tell my students is, that quotes really help make stories. you can think you're a wonderful writer but if you don't have good anecdotes and quotes and good description and good stories to write about, you're going to be spinning your wheels. and i'm going to start off basically with not something i wrote but quotes. the first one involved a visit that dr. king made to the delta in the spring of '68. turns out it was the last days of his life and he was there trying to rally support for the poor people's campaign. imagine here is a man with a nobel prize winner, major figure in the movement. i was only reporter covering him for a couple of days, traveling around the delta. dr. king was with jose williams and ralph abernathy. they drove around in a big sedan. i followed behind them in my little volkswagen beetle. one of the events was at a black church in marks, miss